Risk Assessment Tool Can Help Predict Fractures in CancerOctober 21, 2024MelanomaMixed TopicsNonmelanoma Skin Cancer
The New Cancer Stats Might Look Like a Death Sentence. They Aren’t.October 16, 2024Nonmelanoma Skin CancerMelanomaMixed TopicsBusiness of Medicine
‘Cancer Doesn’t Wait’: How Prior Authorization Harms CareOctober 2, 2024Business of MedicineMelanomaNonmelanoma Skin Cancer
Popular Weight Loss Drugs Now for Patients With Cancer?September 30, 2024Nonmelanoma Skin CancerMelanoma
Does Medicare Advantage Offer Higher-Value Chemotherapy?September 26, 2024MelanomaMixed TopicsNonmelanoma Skin CancerBusiness of Medicine
AACR Cancer Progress Report: Big Strides and Big GapsSeptember 26, 2024MelanomaNonmelanoma Skin CancerDiversity in MedicineMixed TopicsPediatricsBusiness of Medicine
Cancer Risk: Are Pesticides the New Smoking?September 20, 2024MelanomaNonmelanoma Skin CancerBusiness of MedicineMixed Topics
FDA OKs Subcutaneous Atezolizumab Formulation for Multiple Cancer IndicationsSeptember 17, 2024Mixed TopicsMelanoma
Do Clonal Hematopoiesis and Mosaic Chromosomal Alterations Increase Solid Tumor Risk?September 6, 2024Mixed TopicsMelanomaNonmelanoma Skin Cancer
Study Indicates Skin Cancer Risk Elevated Among VeteransSeptember 5, 2024Nonmelanoma Skin CancerMelanoma
Cancer Cases, Deaths in Men Predicted to Surge by 2050August 30, 2024Nonmelanoma Skin CancerMixed TopicsMelanomaBusiness of Medicine
Cancer Treatment 101: A Primer for Non-OncologistsAugust 23, 2024MelanomaMixed TopicsNonmelanoma Skin CancerPediatricsBusiness of Medicine
When Childhood Cancer Survivors Face Sexual ChallengesAugust 22, 2024Mixed TopicsPediatricsDiversity in MedicineNonmelanoma Skin CancerMelanoma
Diagnosing, Treating Rashes In Patients on Immune Checkpoint InhibitorsAugust 21, 2024MelanomaMixed Topics
